
via OHSU
An innovative new technique that encourages cancer cells in the kidneys to self-destruct could revolutionise the treatment of the disease, a new study in the journal Pharmaceutics reports.
During this unique study, researchers from the University of Surrey and Sechenov First Moscow State Medical University in Russia investigated whether certain naturally occurring proteins within the body can be used to treat cancer.
Focusing on cathepsin S, a member of the lysosomal cathepsin proteins that are known to affect cancer progression, and p21 BAX, a protein that can stimulate cell destruction, researchers found that both can be deployed simultaneously to fight cancer cells in a two-pronged ‘attack.’ They act firstly by stopping the mechanism that makes certain treatments of the disease ineffective, and secondly by effectively encouraging cancerous cells to self-destruct.
This revolutionary approach targets two converging regulatory pathways that can sometimes be resistant to chemotherapy and has led to the development of a potential ground-breaking therapy using a novel peptide, CS-PEP1. Researchers found that this peptide inhibits both cathepsin S and its ability to break down the p21 BAX protein, resulting in the accumulation of p21 BAX, which encourages the death of cancer cells in the kidneys. The twin-track effect of this peptide can also override the molecular resistance often found during conventional chemotherapy treatment and offers a novel and effective approach in treating cancer.
An increased focus on therapeutic cancer treatments has signalled a move away from traditional methods such as chemotherapy and radiotherapy, as therapeutic treatments have been found to cause less harm to normal cells and fewer side effects for patients.
Professor Paul Townsend, Principal Investigator, Pro-Vice-Chancellor, and Executive Dean of the Faculty of Health and Medical Sciences at the University of Surrey, said: “Kidney cancer is a very difficult type of cancer to cure; there is an increased need to think innovatively to develop new techniques. We have now discovered that proteins already in the body can be manipulated to encourage cancerous cells to die. This is an extraordinary breakthrough and insight, and can be used to potentially inform the treatment of other types of aggressive cancers, such as cancers of the breast and prostate.”
Original Article: Innovative technique developed to destroy cancerous kidney cells
More from: University of Surrey | First Moscow State Medical University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Encouraging cancerous cells to self-destruct
- The size of skin cancer cells may affect how they respond to treatment
Certain skin cancer cells may differ in how they respond to various treatments according to their size. Better understanding this and how it relates to treatment outcomes could help doctors ...
- Cancer Cells Change Size to Survive Chemotherapy
To survive a drug treatment or other challenges, cancer cells are found to shrink or super-size themselves to adapt to the environment. The study, published today in the journal Science Advances ...
- Cancer Cells Resist Treatment by Manipulating Their Size
combined biochemical profiling technologies with mathematical analyses and found that cancer cells can shrink or super size to survive drug treatment or other obstacles in their environment.
- How regulatory T cells halt aberrant, self-reactive T cells
New research findings show in detail how self-reactive T cells -- white blood cells dubbed ... of properties against insects, fungus and cancer. The experiments conducted in the Savan and Ziegler ...
- Cancer cells may shrink or super-size to survive
Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered. Scientists at The Institute of Cancer Research ...
Go deeper with Google Headlines on:
Encouraging cancerous cells to self-destruct
[google_news title=”” keyword=”encouraging cancerous cells to self-destruct” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Kidney cancer
- Area parlors hold tattoo flash sale to benefit area man battling cancer
The positive impact a community can have on one of its own can be as permanent as a tattoo. For more than 100 people Sunday, the two were one and the same.
- Kidney Cancer Diagnostics And Therapeutics Market Share, Revenue, and Forecasts 2023 to 2029
Kidney Cancer Diagnostics And Therapeutics Market Size is projected to Reach Multimillion USD by 2029, In comparison ...
- Kidney Cancer Market : An Exclusive Study On Upcoming Trends And Growth Opportunities from 2023-2028
Kidney Cancer Market 2023 with 93 Pages Report and enhance with extents shares into sub-counties are covered in ...
- Exelixis Kidney Cancer Survival Benefit Doesn't Address Competitive Question
The Food and Drug Administration is still reviewing the Cometriq kidney cancer data with an approval decision expected on June 22. The drug is also under review by European regulators. Exelixis is ...
- Why kidney cancer is the fastest growing form of the disease
Kidney cancer is the fastest growing type of the disease in women and the increase could be due to rising levels of obesity, experts warned today. New figures from Cancer Research UK show that ...
Go deeper with Google Headlines on:
Kidney cancer
[google_news title=”” keyword=”Kidney cancer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]